1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68: 394-424, 2018. PMID: 30207593. DOI: 10.3322/caac.21492
2. Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. 396:635-648, 2020. PMID: 32861308. Doi: 10.1016/S0140-6736(20)31288-5.
3. Pentheroudakis G; ESMO Guidelines Committee. Recent eUpdates to the ESMO Clinical Practice Guidelines on hepatocellular carcinoma, cancer of the pancreas, soft tissue and visceral sarcomas, cancer of the prostate and gastric cancer. Ann Oncol. 30:1395-1397, 2019. PMID: 31168599. Doi: 10.1093/annonc/mdz180.
4. NCCN. NCCN Clinical Practice Guidelines in Oncology. https://www.nccn.org/professionals/physician_gls/default.aspx
5. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 14: 101-12, 2011. PMID: 21573743. Doi: 10.1007/s10120-011-0041-5.
6. Muro K, Van Cutsem E, Narita Y, Pentheroudakis G, Baba E, Li J, Ryu MH, Zamaniah WIW, Yong WP, Yeh KH, Kato K, Lu Z, Cho BC, Nor IM, Ng M, Chen LT, Nakajima TE, Shitara K, Kawakami H, Tsushima T, Yoshino T, Lordick F, Martinelli E, Smyth EC, Arnold D, Minami H, Tabernero J, Douillard JY. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with metastatic gastric cancer: a JSMO-ESMO initiative endorsed by CSCO, KSMO, MOS, SSO and TOS. Ann Oncol. 30:19-33, 2019. PMID: 30475956. Doi: 10.1093/annonc/mdy502.
7. Shimoda Y, Fujikawa H, Komori K, Watanabe H, Kano K, Yamada T, Shiozawa M, Morinaga S, Katsumata K, Tsuchida A, Ogata T, Oshima T. Preoperative utility of the Glasgow Prognostic Score on outcomes of patients with locally advanced gastric cancer. J Gastrointest Cancer. 2021. PMID: 33460001. Doi: 10.1007/s12029-021-00584-3.
8. Wang N, Xi W, Lu S, Jiang J, Wang C, Zhu Z, Yan C, Liu J, Zhang J. A novel inflammatory-nutritional prognostic scoring system for stage III gastric cancer patients with radical gastrectomy followed by adjuvant chemotherapy. Front Oncol.11:650562, 2021. PMID: 34195071. Doi: 10.3389/fonc.2021.650562.
9. Inoue H, Kosuga T, Kubota T, Konishi H, Shiozaki A, Okamoto K, Fujiwara H, Otsuji E. Significance of a preoperative systemic immune-inflammation index as a predictor of postoperative survival outcomes in gastric cancer. World J Surg Oncol. 19:173, 2021. PMID: 34118953. Doi: 10.1186/s12957-021-02286-3.
10. Zhang X, Fang H, Zeng Z, Zhang K, Lin Z, Deng G, Deng W, Guan L, Wei X, Li X, Jiang L, Xu L. Preoperative Prognostic Nutrition Index as a Prognostic Indicator of Survival in Elderly Patients Undergoing Gastric Cancer Surgery. Cancer Manag Res. 13:5263-5273, 2021. PMID: 34239325. Doi: 10.2147/CMAR.S316437.
11. Keller U. Nutritional Laboratory Markers in Malnutrition. J Clin Med. 31;8:775, 2019. PMID: 31159248. Doi: 10.3390/jcm8060775.
12. Raiten DJ, Sakr Ashour FA, Ross AC, Meydani SN, Dawson HD, Stephensen CB, Brabin BJ, Suchdev PS, van Ommen B; INSPIRE Consultative Group. Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE). 145:1039S-1108S, 2015. Epub 2015 Apr 1. PMID: 25833893. Doi: 10.3945/jn.114.194571.
13. Kawai H, Ota H. Low perioperative serum prealbumin predicts early recurrence after curative pulmonary resection for non-small-cell lung cancer. World J Surg. 36:2853-7, 2012. PMID: 22948197. Doi: 10.1007/s00268-012-1766-y.
14. Kelly P, Paulin F, Lamont D, Baker L, Clearly S, Exon D, Thompson A. Pre-treatment plasma proteomic markers associated with survival in oesophageal cancer. Br J Cancer. 106(5):955-61, 2012. PMID: 22294182. Doi: 10.1038/bjc.2012.15.
15. Cai W, Kong W, Dong B, Zhang J, Chen Y, Xue W, Huang Y, Zhou L, Huang J. Pretreatment Serum Prealbumin as an Independent Prognostic Indicator in Patients With Metastatic Renal Cell Carcinoma Using Tyrosine Kinase Inhibitors as First-Line Target Therapy. Clin Genitourin Cancer. 15:e437-e446, 2017. PMID: 28188047. doi: 10.1016/j.clgc.2017.01.008.
16. Han WX, Chen ZM, Wei ZJ, Xu AM. Preoperative pre-albumin predicts prognosis of patients after gastrectomy for adenocarcinoma of esophagogastric junction. World J Surg Oncol.14:279, 2016. PMID: 27809860. Doi: 10.1186/s12957-016-1035-x.
17. Shen Q, Liu W, Quan H, Pan S, Li S, Zhou T, Ouyang Y, Xiao H. Prealbumin and lymphocyte-based prognostic score, a new tool for predicting long-term survival after curative resection of stage II/III gastric cancer. Br J Nutr. 120:1359-1369, 2018. PMID: 30370885. Doi: 10.1017/S0007114518002854.
18. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 14:101-12, 2011. PMID: 21573743. doi: 10.1007/s10120-011-0041-5.
19. Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K; ACTS-GC Group. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 357:1810-20, 2007. Doi: 10.1056/NEJMoa072252.